Certified by Founder Lodge
Exeliom Biosciences
France - Dijon, Bourgogne-Franche-Comté
START UP
1 Disclosed Funding Rounds $8,898,320
0 Participating Investments
-
Founded date
2016
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
At Exeliom Biosciences, we develop single bacterial strain drug candidates to deliver first-in-class microbiome-based therapeutics (also known as Live Biotherapeutics) for the treatment of im
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| July, 21 ,2023 | Series A | $8,898,320 |
UI Investissement
Auriga Partners SA
Truemeds India
Receptor Life Sciences, Inc.
Koneksa
MAYD: MEDS AT YOUR DOORSTEP
Fullife Healthcare Pvt. Ltd.
Transaera, Inc. | $10,500,000 | (Nov 5, 2024)
Algebrik AI | $4,000,000 | (Nov 5, 2024)
Insider. | $500,000,000 | (Nov 5, 2024)
Cintoo | $40,246,701 | (Nov 5, 2024)
Advex AI | $3,500,000 | (Nov 5, 2024)
